ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meeting

May 26, 1978

ACS Urges Bush To Increase NCI Budget.

January 19, 2007

Study Section Members Likelier to Be Funded

August 1, 1986

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Adriamycin Update Discussed At Seminar

January 10, 1975

House Democrats Take More Swings At Tobacco Industry

February 17, 1989